Redaelli, Marco <br/><br/>
Herpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models.  [electronic resource] 

 -  Neuro-oncology  Mar 2012 
 - 288-301 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-5866 
<br/><br/><label>Standard No.: </label>10.1093/neuonc/nor219  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiviral Agents--therapeutic use<br/>Brain Neoplasms--therapy<br/>Cattle<br/>Disease Models, Animal<br/>Ganciclovir--therapeutic use<br/>Genetic Therapy<br/>Genetic Vectors<br/>Glioma--therapy<br/>Herpesvirus 1, Human--genetics<br/>Herpesvirus 4, Bovine--genetics<br/>Humans<br/>Immunocompetence<br/>Mice<br/>Mice, Inbred C57BL<br/>Oncolytic Viruses--genetics<br/>Prodrugs--therapeutic use<br/>Rats<br/>Rats, Inbred F344<br/>Thymidine Kinase--genetics<br/>Tumor Cells, Cultured